Rite Aid is a pharmaceutical retailer company located in Pennsylvania, United States, which is part of the Consumer Defensive sector, and is traded under the ticker RAD on the NYSE exchange.
Rite Aid stock last closed at $2.68, down 4.96% from the previous day, and has decreased 70.96% in one year. It has underperformed other stocks in the Pharmaceutical Retailers industry by 0.18 percentage points. Rite Aid stock is currently +10.52% from its 52-week low of $2.43, and -76.91% from its 52-week high of $11.61.
At the moment, there are 56.52M shares of RAD outstanding. The market cap of RAD is $151.48M. In the past 24 hours, 6.42M RAD shares were traded.
You will need an online brokerage account to access the NYSE market and buy RAD stock.
Based on our research, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in RAD stock today.
Now that you've filled out your info on one of the most highly reviewed stock trading apps, you can securely and quickly fund your account:
Check out the video below to see the process of transferring funds into your new brokerage account.
Once you have chosen the best place to buy Rite Aid stock, it's critical to analyze their stock prior to buying, so you actually understand the risk as well as the upside.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on RAD's stock page.
You can use many financial metrics, analyses, models, and charts to gauge RAD's true value.
You can access additional valuation analysis on RAD's stock here.
Out of 2 Equities analysts who monitor RAD, the consensus analyst rating on RAD is a Strong Sell
Please note that analyst forecasts are not recommendations, nor are they investment advice.
George Hill, a top 12% analyst from Deutsche Bank maintains RAD with a strong sell rating and lowers their RAD price target from $4.00 to $3.00, on Oct 3, 2022.
Elizabeth Anderson, a bottom 11% analyst from Evercore ISI Group maintains RAD with a sell rating and lowers their RAD price target from $7.00 to $4.50, on Sep 30, 2022.
You can dive deeper into what analysts are forecasting on the Rite Aid stock forecast page.
Last year, RAD revenue was $24.06B. During the last five year, RAD's revenue has grown by 6.97% per year. This was faster than the Pharmaceutical Retailers industry average of 2.77%.
You can analyze RAD's earnings and revenue performance here.
Over the last 12 months, executives and large shareholders at RAD have sold more shares than they have bought.
Andre Persaud, EVP Retail of RAD, was the latest RAD insider to sell. They sold $7,805.76 worth of RAD stock on Feb 3, 2023.
Learn more about who owns RAD stock here.
No, Rite Aid doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary types of orders:
Click the Open button and your broker will place your order.
If you require more help with buying stocks on eToro, click the how to video below:
Now that you own some RAD shares, you'll want to keep up with your new investment.
Start a watchlist to see the latest developments about your RAD stock.
To summarize, here are the 6 steps you need to take to buy Rite Aid stock right now:
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your investment in Rite Aid, get started below.